welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, and Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that the companies have executed a term sheet under which Microlin intends to acquire Marina’s nucleic acid therapeutics assets.
expertly curated content related to this topic
-
18F-FES PET/CT in Imaging Patients With Desmoid TumorsThis pilot clinical trial studies fluori...
-
polyposis (polypeople)FAP is an inherited condition which main...
-
Hidden Heartache: The Untold Story of Bowel CancerEvery 15 minutes someone is diagnosed wi...
-
Dana-Farber Cancer InstituteSpeciality Clinic Patient Resources: ...
-
French Digestive Polyposis CohorteFrench cohorte about polyposis digestive...
-
Thomas T. Amatruda, MDSpecialties Genetics Hematology Inter...
-
@MyGeneCounsel#Geneticcounselor, #President & #CEO...